A Promising ‘Single’ and ‘Dual’ Drug-Nanocomposite Enriched Contact Lens for the Management of Glaucoma in Response to Tear Fluid Enzyme

Glaucoma is a neurodegenerative condition that results in the damage of retinal ganglion cells due to elevated intraocular pressure (IOP). To curtail the limitations with conventional treatments such as eye...